Armata Pharmaceuticals, Inc. announced a new publication.
Published
Signal category
Capital & Finance
Quote
“Armata Pharmaceuticals, Inc. announces new publication”
— Armata Pharmaceuticals, Inc. team
Company
Armata Pharmaceuticals, Inc.
PURPOSEFUL. PRECISE. POWERFUL.
- Industry
- Biotechnology Research
- Location
- Los Angeles, US
- Company size
- 75 employees
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific cGMP manufacturing. More information is available at www.armatapharma.com
Founded 2019